TCR2 Therapeutics Inc (NASDAQ:TCRR)
| 23.16 Delayed Data As of 3:59pm ET |  -0.59 / -2.48%Today’s Change | 8.63 Today|||52-Week Range 35.86 | -25.12% Year-to-Date |
Latest TCRR News | Press Releases
No recent news for TCR2 Therapeutics Inc.
Today’s Trading
| Previous close | 23.75 |
| Today’s open | 23.55 |
| Day’s range | 23.11 - 24.09 |
| Volume | 22,332 |
| Average volume (3 months) | 584,763 |
| Market cap | $905.0M |
Data as of 3:59pm ET, 04/19/2021
Growth & Valuation
| Earnings growth (last year) | +48.09% |
| Earnings growth (this year) | +6.30% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 3.36 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| VNDAVanda Pharmaceutical... | -0.20 | -1.20% |
| STROSutro Biopharma Inc | -1.32 | -6.60% |
| ---- | ||
| AKROAkero Therapeutics I... | -0.32 | -1.17% |
Data as of 4:00pm ET, 04/19/2021
Financials
| Next reporting date | May 19, 2021 |
| EPS forecast (this quarter) | -$0.53 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$67.1M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
